About AT-Vienna-HANUSCH
Das Hanusch-Krankenhaus befindet sich im 14. Wiener Gemeindebezirk in der Heinrich-Collin-Straße 30. Es ist ein Krankenhaus mit zehn Abteilungen und sieben Instituten, darunter das Ludwig-Boltzmann-Institut, ein Forschungsinstitut für Osteologie und Leukämie-Forschung.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Stichting Hemato-Oncologie voor Volwassenen Nederland
3
Clinical Trials at AT-Vienna-HANUSCH
During the past decade, AT-Vienna-HANUSCH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma
2011-01-01
2023-04-01
Unknown status
1,503
A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy
2019-03-01
2033-03-01
Recruiting
968
A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy
2019-12-20
2033-06-01
Recruiting
768
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AT-Vienna-HANUSCH"
#1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator and "European Myeloma Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at AT-Vienna-HANUSCH
According to Clinical.Site data, the most researched conditions in "AT-Vienna-HANUSCH" are
"Acute Myeloid Leukemia" (2 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "AT-Vienna-HANUSCH" in a lesser frequency.
Clinical Trials Intervention Types at AT-Vienna-HANUSCH
Most popular intervention types in "AT-Vienna-HANUSCH" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "AG-120" (1 trials), "AG-221" (1 trials) and "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AT-Vienna-HANUSCH
The vast majority of trials in "AT-Vienna-HANUSCH" are
3 trials for "All" genders.
Clinical Trials Status at AT-Vienna-HANUSCH
Currently, there are NaN active trials in "AT-Vienna-HANUSCH".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in AT-Vienna-HANUSCH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in AT-Vienna-HANUSCH, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".